Molecular Mechanism and Cannabinoid Pharmacology.

Schurman, Lesley D; Lu, Dai; Kendall, Debra A; Howlett, Allyn C; Lichtman, Aron H

Schurman, Lesley D; Lu, Dai; Kendall, Debra A; Howlett, Allyn C; Lichtman, Aron H.

Afiliación

Schurman LD; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Lu D; Rangel College of Pharmacy, Health Science Center, Texas A&M University, Kingsville, TX, USA.
Kendall DA; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
Howlett AC; Department of Physiology and Pharmacology and Center for Research on Substance Use and Addiction, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Lichtman AH; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. aron.lichtman@vcuhealth.org.

Handb Exp Pharmacol ; 258: 323-353, 2020.

Article en En | MEDLINE | ID: mdl-32236882

Asunto(s)

Endocannabinoides/fisiología; Receptor Cannabinoide CB1/fisiología; Receptor Cannabinoide CB2/fisiología; Cannabidiol/farmacología; Cannabinoides/farmacología; Dronabinol/farmacología; Humanos

Palabras clave

Allosteric modulation; CB1/CB2 receptor; CBD; Cannabinoid; Cannabis Use Disorder; Endocannabinoid; Opioid-sparing effects; Phytocannabinoid; Synthetic cannabinoid; THC

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor Cannabinoide CB1 / Receptor Cannabinoide CB2 / Endocannabinoides Límite: Humans Idioma: En Revista: Handb Exp Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google